BAY 1135626

SKU: orb2564848

Description

BAY 1135626 is a synthetic precursor to BAY 1129980, an Auristatin-based antibody-drug conjugate (ADC) targeting C4.4A (LYPD3). This ADC is utilized in non-small cell lung cancer (NSCLC) research, with studies investigating its anti-tumor activity in both in vitro and in vivo experimental models.

Key Properties

• CAS Number: 1404071-37-9
• MW: 1063.33
• Formula: C₅₅H₈₆N₁₀O₁₁
• SMILES: C([C@H](NC([C@@H]([C@@H](OC)[C@]1(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(CCCC(NNC(CCCCCN2C(=O)C=CC2=O)=O)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC1)[H])C)=O)C(N)=O)C=3C=4C(NC3)=CC=CC4
• Target: Drug-Linker Conjugates for ADC

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

86678384